Even though there is no energy involved in the transport mechanism of SLC2A1 and SLC2A3, the increased density of these transporters in the plasma membrane due to increased HIF-1α-induced transcription results in an increased influx of glucose from the circulation into cancer cells to feed into the glycolytic pathway. The gene discussed is SLC2A3; the disease is cancer.